In studies comparing marker levels in newly diagnosed cases to non-cases, most [9, 11, 12], but not all [10, 23–25], found higher levels of circulating VEGF or PlGF in breast cancer cases than in non-cases, which may reflect local tumor production [26]. This evidence concerns the gene PGF and breast cancer.